Valuation : Divi's Laboratories Limited

Market Cap 2,513B 26.41B 22.74B 21.35B 19.49B 36.62B 36.88B 253B 98.45B 1,274B 99.17B 97.02B 4,220B P/E 2027 *
77.1x
P/E 2028 * 64x
Enterprise Value 2,478B 26.05B 22.43B 21.06B 19.22B 36.11B 36.37B 250B 97.08B 1,257B 97.79B 95.67B 4,161B EV / Sales 2027 *
19.7x
EV / Sales 2028 * 16.5x
Free-Float
48.01%
Yield 2027 *
0.37%
Yield 2028 * 0.41%
1 day+2.47%
1 week+10.12%
Current month+17.51%
1 month+20.83%
3 months+42.00%
6 months+47.84%
Current year+48.10%
1 week 8,497
Extreme 8497
9,467
1 month 8,105
Extreme 8105
9,467
Current year 5,647.5
Extreme 5647.5
9,467
1 year 5,636.5
Extreme 5636.5
9,467
3 years 3,295.3
Extreme 3295.3
9,467
5 years 2,730
Extreme 2730
9,467
10 years 532.65
Extreme 532.65
9,467
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.47%+10.12%+54.40%+160.74% 25.66B
-1.52%-6.97%+57.78%+109.31% 1,047B
-0.61%-2.36%+49.72%+64.89% 646B
+0.25%-2.99%+21.08%+74.61% 451B
-1.64%-4.75%+35.59%+35.54% 355B
-0.39%-2.76%+21.39%+38.01% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-0.41%-2.78%+50.39%+68.33% 234B
-1.05%-2.29%-19.91%-54.10% 203B
+0.47%-0.17%+29.97%+91.54% 181B
Average -0.48%-1.66%+30.19%+60.04% 368.49B
Weighted average by Cap. -0.95%-3.38%+36.88%+65.75%

Financials

2027 *2028 *
Net sales 126B 1.32B 1.14B 1.07B 975M 1.83B 1.85B 12.66B 4.93B 63.77B 4.96B 4.85B 211B 150B 1.58B 1.36B 1.27B 1.16B 2.18B 2.2B 15.09B 5.87B 76.01B 5.92B 5.79B 252B
Net income 32.65B 343M 295M 277M 253M 476M 479M 3.29B 1.28B 16.56B 1.29B 1.26B 54.82B 39.42B 414M 357M 335M 306M 574M 578M 3.97B 1.54B 19.99B 1.56B 1.52B 66.18B
Net Debt -35B -368M -317M -297M -271M -510M -514M -3.52B -1.37B -17.75B -1.38B -1.35B -58.76B -44.85B -471M -406M -381M -348M -654M -658M -4.52B -1.76B -22.74B -1.77B -1.73B -75.31B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
31/08/26 9,467.00 +2.47% 680,805
28/08/26 ₹9,239.00 +1.98% 773,225
27/08/26 ₹9,060.00 +0.39% 527,307
26/08/26 ₹9,025.00 +3.21% 708,128
25/08/26 ₹8,744.50 +2.92% 563,721
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,467.00INR
Average target price
8,447.00INR
Spread / Average Target
-10.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock